156 related articles for article (PubMed ID: 24501870)
1. [A clinical case of young, oral combined contraceptive using women, heterozygous carrier of the Factor V (Leiden) which revealed thrombosis of the left internal jugular vein and brain ischemia with cerebral infarction and ischemic stroke].
Kovachev S; Ramshev K; Ramsheva Z; Ivanov A; Ganovska A
Akush Ginekol (Sofiia); 2013; 52(5):54-7. PubMed ID: 24501870
[TBL] [Abstract][Full Text] [Related]
2. Can a change in screening and prescribing practice reduce the risk of venous thromboembolism in women taking the combined oral contraceptive pill?
Mills A; Wilkinson C; Fotherby K
Br J Fam Plann; 1998 Jan; 23(4):112-5. PubMed ID: 9882763
[TBL] [Abstract][Full Text] [Related]
3. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Kemmeren JM; Algra A; Meijers JC; Bouma BN; Grobbee DE
Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
[TBL] [Abstract][Full Text] [Related]
4. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
5. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors.
Tanis BC; Rosendaal FR
Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494
[TBL] [Abstract][Full Text] [Related]
6. Deep vein thrombosis followed by internal jugular vein thrombosis as a complication of in vitro fertilization in a woman heterozygous for the prothrombin 3' UTR and factor V Leiden mutations.
McGowan BM; Kay LA; Perry DJ
Am J Hematol; 2003 Aug; 73(4):276-8. PubMed ID: 12879433
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study.
Wu O; Robertson L; Langhorne P; Twaddle S; Lowe GD; Clark P; Greaves M; Walker ID; Brenkel I; Regan L; Greer IA
Thromb Haemost; 2005 Jul; 94(1):17-25. PubMed ID: 16113779
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive use, thrombophilia and their interaction in young women with ischemic stroke.
Martinelli I; Battaglioli T; Burgo I; Di Domenico S; Mannucci PM
Haematologica; 2006 Jun; 91(6):844-7. PubMed ID: 16769590
[TBL] [Abstract][Full Text] [Related]
9. The risk of venous thrombosis, including cerebral vein thrombosis, among women with thrombophilia and oral contraceptive use: a meta-analysis.
Dayan N; Holcroft CA; Tagalakis V
Clin Appl Thromb Hemost; 2011; 17(6):E141-52. PubMed ID: 21220364
[TBL] [Abstract][Full Text] [Related]
10. Oral contraception in women with mild thrombophilia: what have we learned recently?
Blanco-Molina Á
Thromb Res; 2012 Oct; 130 Suppl 1():S16-8. PubMed ID: 23026651
[TBL] [Abstract][Full Text] [Related]
11. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
[TBL] [Abstract][Full Text] [Related]
12. Consequences of thrombophilia screening for life quality in women before prescription of oral contraceptives and family members of VTE patients.
Eichinger S
Hamostaseologie; 2009 Jan; 29(1):110-1. PubMed ID: 19151859
[TBL] [Abstract][Full Text] [Related]
13. Effect of age on oral contraceptive-induced venous thrombosis.
Girolami A; Spiezia L; Girolami B; Zocca N; Luzzatto G
Clin Appl Thromb Hemost; 2004 Jul; 10(3):259-63. PubMed ID: 15247983
[TBL] [Abstract][Full Text] [Related]
14. Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptives.
Pezzini A; Grassi M; Iacoviello L; Del Zotto E; Archetti S; Giossi A; Padovani A
J Neurol Neurosurg Psychiatry; 2007 Mar; 78(3):271-6. PubMed ID: 17098841
[TBL] [Abstract][Full Text] [Related]
15. Venous thrombosis in oral contraceptive users and the presence of the JAK2 V617F mutation.
Grandone E; Colaizzo D; Tiscia GL; Vergura P; Chinni E; Iannaccone L; Antinolfi I; Guardascione MA; Margaglione M
Thromb Haemost; 2008 Mar; 99(3):640-2. PubMed ID: 18327418
[No Abstract] [Full Text] [Related]
16. Oral contraceptives and inherited thrombophilia: a gene-environment interaction with a risk of venous thrombosis?
Mac Gillavry MR; Prins MH
Semin Thromb Hemost; 2003 Apr; 29(2):219-26. PubMed ID: 12709926
[TBL] [Abstract][Full Text] [Related]
17. Thrombophilia and the risk of thromboembolic events in women on oral contraceptives and hormone replacement therapy.
DeSancho MT; Dorff T; Rand JH
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):534-8. PubMed ID: 20581664
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
19. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
20. [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].
Bauersachs R; Lindhoff-Last E; Ehrly AM; Kuhl H
Zentralbl Gynakol; 1996; 118(5):262-70. PubMed ID: 8701622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
